SyntheticMR's unique SyMRI technology measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single fast scan. SyMRI is designed to help you save valuable time by reducing scan time, all the while aiding as an objective decision support for diagnosis and patient follow-ups. SyMRI offers a fast and standardized protocol with clinically relevant quantitative data for more robust assessments of patients. SyMRI NEURO spans across all age groups, from neonates to adults, empowering radiologists and clinicians with confident, robust, and rapid quantitative assessments. Using a single fast scan, SyMRI NEURO provides a myriad of qualitative images (T1w, T2w, FLAIR, etc.), quantitative maps, and volumes, including our first-of-a-kind quantitative myelin maps. Our latest innovation, SyMRI 3D, is poised to revolutionize the field of medical imaging by introducing a myriad of innovative applications within SyMRI's post-processing solution. SyMRI 3D enables precise volumetric estimations of brain regions, a technique commonly referred to as parcellation, which empowers clinicians to gain deeper insights into brain structure and function. SyntheticMR AB is headquartered in Linköping, Sweden with sales representation in the USA, Europe, Japan and India. The company was founded in 2007 and is listed on the AktieTorget exchange in Stockholm, Sweden.